PSMA PET/CT May Discriminate Clinically Significant Prostate Cancer for Biopsy
Use of 68 Ga-PSMA PET/CT may avoid unnecessary biopsies in some men with equivocal PI-RADS 3 lesions on mpMRI.
Use of 68 Ga-PSMA PET/CT may avoid unnecessary biopsies in some men with equivocal PI-RADS 3 lesions on mpMRI.
Benefits seen for genitourinary and gastrointestinal toxic effects
Prostate cancer has one of the largest racial disparities in outcomes between Black and White patients, according to investigators.
Implementation of on-site guideline-based genetic testing for prostate cancer patients increased compliance from 33.3 to 98.7%
Increase in annual attributable costs observed over time, from $28,311 in 2007-2013 to $37,055 in 2014-2017
Investigators examined the risk of bone fracture associated with different forms of androgen deprivation therapy.
Incidence and mortality rates for major genitourinary cancers differ according to sex, race/ethnicity, and geographic region.
Data suggest that 125 men active surveillance would need to receive initial treatment to prevent 1 prostate cancer death at 10 years.
An international panel weighed in on management controversies in intermediate- and high-risk and locally advanced prostate cancer.
A new product called iQuest has the potential to define the extent of cancer more accurately.